# Minocycline Hydrochloride in Reducing Chemotherapy-Induced Peripheral Neuropathy and Acute Pain in Patients With Breast Cancer Undergoing Treatment With Paclitaxel

> **NCT02297412** · PHASE2 · COMPLETED · sponsor: **Academic and Community Cancer Research United** · enrollment: 47 (actual)

## Conditions studied

- Acute Pain
- Breast Carcinoma
- Peripheral Neuropathy

## Interventions

- **DRUG:** Minocycline Hydrochloride
- **OTHER:** Placebo
- **OTHER:** Quality-of-Life Assessment
- **OTHER:** Questionnaire Administration

## Key facts

- **NCT ID:** NCT02297412
- **Lead sponsor:** Academic and Community Cancer Research United
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11
- **Primary completion:** 2016-07-08
- **Final completion:** 2016-07-08
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2022-01-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02297412

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02297412, "Minocycline Hydrochloride in Reducing Chemotherapy-Induced Peripheral Neuropathy and Acute Pain in Patients With Breast Cancer Undergoing Treatment With Paclitaxel". Retrieved via AI Analytics 2026-09-28 from https://api.ai-analytics.org/clinical/NCT02297412. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*